6 Neurology And CNS Disorders companies

Invested in breaking ‍through paralysis.

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

We build and invest in companies that transform healthcare.

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation.

A CHF 50M venture capital fund aimed at supporting the development of neuroenhancement technologies.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…